Cancer waiting time audit - flowcharts

Cancer waiting time audit - flowcharts

Français
24 pages
Lire
Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres

Description

Appendix 5: flow chartsSingle site brain and CNS cancer studiesResearch Study (n=0)Brain &CNS(n=1)Below threshold (n=0)Clinical audit (n=1)Above threshold (n=1)Population = cancer patients Population = cancer Population = referralsand referrals (n=0) patients (n=0) (n=1)Urgent referrals (n=1)All referrals (n=0)Key: B&A = before and after studyAudit number Sample size(WTA 1) (B&A) 45Multiple site brain and CNS cancer studiesResearch Study (n=0)Multiple sitestudiesincludingBrain & CNSBelow threshold (n=0)(n=11)Clinical audit (n=11)Above threshold (n=11)Population = cancer Population = cancer Population = referralspatients and referrals (n=1) patients (n=0) (n=10)All referrals (n=0) Urgent referrals (n=10)Audit number N Brain and CNS(WTA 212) 1Audit number N Brain and CNS(WTA 207) 2(WTA 232) 2(WTA 230) 2(WTA 206) 2(WTA 231) 3(WTA 210) 4(WTA 209) 4(WTA 229) 9(WTA 234) 13(WTA 233) 13Single site breast cancer studiesBelow threshold (n=0)Research Study (n=1)Above threshold (n=1) Population = all Audit number Sample size(WTA 19) 177referrals (n=1)Breast(n=43)Audit number (WTA 42)(WTA 36) (WTA 44)Below threshold (n=9)(WTA 41) (WTA 16)Clinical audit (n=42) (WTA 34) (WTA 8)(WTA 23) (WTA 9)Above threshold (n=33)Population = referrals(n=26)Population = cancer Population = cancerpatients and referrals (n=2) patients (n=5)All referrals (n=21) Urgent referrals (n=5)Audit number Sample size Audit number Sample size(WTA 31) ...

Sujets

Informations

Publié par
Nombre de lectures 93
Langue Français
Signaler un problème
Appendix5:flowchartsSinglesitebrainandCNScancerstudiesBrain&(CnN=S1)ResearchStudy(n=0)Clinicalaudit(n=1)Population=cancerpatientsandreferrals(n=0)Key:B&A=beforeandafterstudyBelowthreshold(n=0)Abovethreshold(n=1)Population=cancerpatients(n=0)Population=referrals=n()1Urgentreferrals(n=1)AuditnumberSamplesize(WTA1)(B&A)45Allreferrals(n=0)
MultiplesitebrainandCNScancerstudiesMultiplesitestudiesincludingBrain&CNS(n=11)ResearchStudy(n=0)Clinicalaudit(n=11)Population=cancerpatientsandreferrals(n=1)AuditnumberNBrainandCNS(WTA212)1Belowthreshold(n=0)Abovethreshold(n=11)Population=cancerpatients(n=0)Allreferrals(n=0)Population=referrals(n=10)Urgentreferrals(n=10)AuditnumberNBrainandCNS(WTA207)2(WTA232)2(WTA230)2(WTA206)2(WTA231)3(WTA210)4(WTA209)4(WTA229)9(WTA234)13(WTA233)13
SinglesitebreastcancerstudiesResearchStudy(n=1)Breast(n=43)Clinicalaudit(n=42)Population=cancerpatientsandreferrals(n=2)AuditnumberSamplesize(WTA31)496(WTA2)(B&A)Key:B&A=beforeandafterstudyBelowthreshold(n=0)Abovethreshold(n=1)Belowthreshold(n=9)Abovethreshold(n=33)Population=cancerpatients(n=5)AuditnumberSamplesize(WTA3)45(WTA4)50(WTA6)51(WTA7)55(WTA43)(B&A)5750Population=allreferrals(n=1)Auditnumber(WTA42)(WTA36)(WTA44)(WTA41)(WTA16)(WTA34)(WTA8)(WTA23)(WTA9)AuditnumberSamplesize(WTA19)177Population=referrals(n=26)Allreferrals(n=21)Urgentreferrals(n=5)AuditnumberSamplesizeAuditnumberSamplesizeAuditnumberSamplesize(WTA5)50(WTA26)249(WTA11)83(WTA10)80(WTA29)408(WTA14)102(WTA12)97(WTA30)432(WTA27)324(WTA13)99(WTA32)594(WTA28)380(WTA15)119(WTA35)966(WTA21)(B&A)200(WTA17)138(WTA37)1250(WTA18)154(WTA38)1433(WTA20)200(WTA39)1440(WTA22)220(WTA40)1585(WTA24)239(WTA33)(B&A)607(WTA25)243
MultiplesitebreastcancerstudiesResearchStudy(n=0)MultiplesitestudiesincludingBreast(n=29)Belowthreshold(n=2)Clinicalaudit(n=29)Abovethreshold(n=27)Population=cancerPopulation=cancerpatientsandreferrals(n=7)patients(n=4)AuditnumberNBreastAuditnumberNBreast(WTA223)104(WTA208)23(WTA212)363(WTA227)23(WTA220)510(WTA224)49(WTA213)646(WTA221)(B&A)(WTA214)983(WTA215)1024(WTA222)3288Key:B&A=beforeandafterstudyUnclear(n=1)AuditnumberNBreast(WTA218)261Auditnumber(WTA211)(WTA216)Population=referrals(n=16)Allreferrals(n=2)AuditnumberBreNast(WTA225)146(WTA218)(B&A)2504Urgentreferrals(n=13)AuditnumberNBreast(WTA226)50(WTA209)63(WTA210)87(WTA217)110(WTA219)170(WTA232)170(WTA206)214(WTA231)217(WTA229)243(WTA230)269(WTA233)449(WTA234)494(WTA207)706
Singlesitechildren’scancerstudies(Cnh=il1d)rensResearchStudy(n=0)Clinicalaudit(n=1)Population=cancerpatientsandreferrals(n=0)Belowthreshold(n=0)Abovethreshold(n=1)Population=cancerpatients(n=0)Allreferrals(n=0)Population=referrals=n()1Urgentreferrals(n=1)AuditnumberSamplesize(WTA45)15
Multiplesitechildren’scancerstudiesMultiplesitestudiesincludingChildren’s)8=n(ResearchStudy(n=0)Clinicalaudit(n=8)Population=cancerpatientsandreferrals(n=0)Belowthreshold(n=0)Abovethreshold(n=8)Population=cancerpatients(n=1)AuditnumberNChildrenscancers(WTA224)3Allreferrals(n=0)Population=referrals)7=n(Urgentreferrals(n=7)AuditNChildrensnumbercancers(WTA207)(WTA230)(WTA206)(WTA233)(WTA232)(WTA231)(WTA234)11122511
SinglesitelowerGIcancerstudies(GnI=l3o9w)erResearchStudy(n=6)Clinicalaudit(n=33)Population=cancerpatientsandreferrals(n=5)AuditnumberSamplesize(WTA57)78(WTA63)114(WTA69)197(WTA74)299(WTA84)2663Belowthreshold(n=2)Abovethreshold(n=4)Population=cancerpatients(n=2)AuditnumberSamplesize(WTA58)(B&A)90(WTA73)(B&A)273Belowthreshold(n=13)Abovethreshold(n=20)Population=cancerpatients(n=0)Auditnumber(WTA81)(WTA83)Population=referrals)2=n(Urgentreferrals(n=1)Allreferrals(n=1)AuditnumberSamplesizeAuditnumberSamplesize(WTA82)(B&A)824(WTA79)(B&A)421Auditnumber(WTA50)(WTA62)(WTA67)(WTA78)(WTA52)(WTA71)(WTA46)(WTA47)(WTA60)(WTA72)(WTA49)(WTA59)(WTA75)Population=referrals(n=15)Allreferrals(n=3)Urgentreferrals(n=12)AuditnumberSamplesize(AWuTdiAt4n8u)mberSamplesi3z4e(AWuTdiAt6n4u)mberSamples1i2z2e(WTA53)65(WTA51)51(WTA66)160(WTA65)124(WTA54)67(WTA70)237(WTA68)183(WTA55)68(WTA76)319(WTA56)69(WTA77)342(WTA61)100(WTA80)466
MultiplesitelowerGIcancerstudiesResearchStudy(n=0)MultiplesitestudiesincludingGIAuditnumberlower(WTA211)(n=32)Belowthreshold(n=4)(WTA239)(WTA216)Clinicalaudit(n=32)(WTA237)Abovethreshold(n=28)Population=referralsPopulation=cancerPopulation=cancer(n=18)patientsandreferrals(n=7)patients(n=3)Unclear(n=1)Allreferrals(n=2)Urgentreferrals(n=15)AuditnumberNLowerGIAuditNLower(WTA235)56numberGI(WTA223)57(WTA227)16AuditnumberNLowerGIAuditnumberNLowerGIAuditnumberNLowerGI(WTA212)144(WTA208)24(WTA228)77(WTA225)24(WTA226)50(WTA215)873(WTA238)28(WT218)(B&A)(WTA219)52(WTA214)1061(WTA229)56(WTA213)1334(WTA217)58(WTA222)1678(WTA210)62(WTA209)73(WTA206)109(WTA231)111(WTA232)153(WTA240)160(WTA230)183(WTA233)372(WTA234)474(WTA207)634(WTA236)(B&A)142
SinglesiteupperGIcancerstudiesuGpIper(n=23)Belowthreshold(n=1)ResearchStudy(n=2)Abovethreshold(n=1)Belowthreshold(n=9)Clinicalaudit(n=21)Abovethreshold(n=12)Population=cancerpatientsandreferrals(n=2)AuditnumberSamplesize(WTA103)208(WTA105)383Population=cancerpatients(n=1)AuditnumberSamplesize(WTA101)124Auditnumber(WTA97)Population=cancerpatients(n=1)Auditnumber(WTA85)(WTA91)(WTA86)(WTA94)(WTA88)(WTA99)(WTA92)(WTA102)(WTA98)AuditnumberSamplesize(WTA104)235Population=referrals)9=n(Allreferrals(n=1)AuditnumberSamplesize(WTA107)1330Urgentreferrals(n=8)AuditnumberSamplesize(WTA87)23(WTA89)47(WTA90)61(WTA93)63(WTA95)79(WTA96)81(WTA100)109(WTA106)547
MultiplesiteupperGIcancerstudiessMtuudlitiepslesiteincludingGI(unp=p3e1r)ResearchStudy(n=0)Belowthreshold(n=4)Clinicalaudit(n=31)Abovethreshold(n=27)Population=cancerpatientsandreferrals(n=8)AuditnumberNUpperGI(WTA223)48(WTA235)64(WTA212)64(WTA220)295(WTA213)636(WTA215)813(WTA214)834(WTA222)995Population=cancerpatients(n=3)AuditnumberNUpperGI(WTA208)7(WTA238)10(WTA227)13Auditnumber(WTA239)(WTA211)(WTA216)(WTA237)Population=referrals(n=16)Allreferrals(n=2)AuditnumberNUpperGI(WTA225)45(WTA218)(B&A)Urgentreferrals(n=14)AuditnumberNUpperGI(WTA217)13(WTA219)20(WTA209)32(WTA226)46(WTA210)48(WTA231)52(WTA232)70(WTA206)77(WTA230)143(WTA229)154(WTA233)204(WTA234)252(WTA207)449(WTA236)(B&A)70
SinglesitegynaecologicalcancerstudiesResearchStudy(n=0)Gynae-cological(n=16)Belowthreshold(n=4)Clinicalaudit(n=16)Abovethreshold(n=12)Population=cancerpatientsandreferrals(n=1)AuditnumberSamplesize(WTA118)162Population=cancerpatients(n=1)AuditnumberSamplesize(WTA114)54Auditnumber(WTA108)(WTA109)(WTA121)(WTA123)Allreferrals(n=3)Population=referrals(n=10)AuditnumberSamplesize(WTA111)51(WTA117)146(WTA122)578Urgentreferrals(n=7)AuditnumberSamplesize(WTA110)35(WTA112)52(WTA113)54(WTA115)77(WTA116)137(WTA119)261(WTA120)273